Capital Group Private Client Services’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $349K | Sell |
1,070
-786
| -42% | -$256K | ﹤0.01% | 266 |
|
|
2025
Q1 | $501K | Sell |
1,856
-39,669
| -96% | -$10.7M | ﹤0.01% | 250 |
|
|
2024
Q4 | $9.77M | Sell |
41,525
-924
| -2% | -$217K | 0.09% | 154 |
|
|
2024
Q3 | $11.7M | Sell |
42,449
-675
| -2% | -$186K | 0.11% | 148 |
|
|
2024
Q2 | $10.5M | Sell |
43,124
-11,297
| -21% | -$2.75M | 0.1% | 143 |
|
|
2024
Q1 | $8.13M | Buy |
54,421
+4,660
| +9% | +$696K | 0.08% | 152 |
|
|
2023
Q4 | $9.52M | Buy |
49,761
+43,500
| +695% | +$8.33M | 0.1% | 140 |
|
|
2023
Q3 | $1.11M | Sell |
6,261
-93
| -1% | -$16.5K | 0.01% | 205 |
|
|
2023
Q2 | $1.21M | Buy |
+6,354
| New | +$1.21M | 0.01% | 195 |
|